top of page

FDA PDUFA Calendar

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates. These are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.

 

The FDA will typically issue one of the following decisions:

  • CRL - complete response letter - rejection letter noting reasons

  • Marketing approval - approved to market under the given label

 

Sometimes the FDA requires an advisory committee meeting prior to the approval decision. This meeting is a public discussion with committee members of various relevant backgrounds, which usually concludes in a vote regarding the efficacy and safety of the drug in question. The FDA is may use this discussion and vote as a guideline for their decision but by no means are bound to this discussion or vote.

Create a free account to search the FDA Catalyst Calendar or start your 7-day free trial of BPIQ Pro today for unlimited access and to see our Big Mover stocks to watch.

Ticker
Drug
Indication
PDUFA Date
MRK
KEYTRUDA (pembrolizumab) injection
Gastric and gastroesophageal junction adenocarcinoma
TBA
RHHBY
Tecentriq w/ ENHANZE®
Solid tumors & various cancer types
TBA
PTCT
Translarna (ataluren)
Nonsense mutation Duchenne muscular dystrophy (nmDMD)
TBA
BMY
OPDIVO (nivolumab) injection
Gastric and gastroesophageal junction adenocarcinoma
TBA
AZN
Andexxa (andexanet alfa)
Intracranial haemorrhage
TBA
NVS
Fabhalta® (iptacopan)
C3 glomerulopathy (C3G)
Feb 24, 2025
THTX
Tesamorelin (F8 Formulation)
HIV-Associated Excess Abdominal Fat
March 25, 2025
GSK
Gepotidacin
Uncomplicated Urinary Tract Infection (uUTI)
March 26, 2025
SLNO
DCCR (Diazoxide Choline Controlled-Release) (K ATP agonist)
PWS (Prader-Willi syndrome)
March 27, 2025
MIST
Etripamil (CARDAMYST) (calcium channel blocker)
(PSVT) Paroxysmal Supraventricular Tachycardia
March 27, 2025
Page 1 of 1

*Want to see all the upcoming FDA catalyst events? Check out our FDA Catalyst Calendar

bottom of page